Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Solve supply chain risks with this mild, high-yield palladium-catalyzed route for benzodihydrofuran intermediates. 80%+ yields, broad functional group tolerance, and scalable to 100MT/yr.
Overcome low yields & noble metal costs in dibenzoazepine synthesis. NINGBO INNO PHARMCHEM delivers 85%+ yield, 99% purity, and GMP-compliant scale-up for pharma R&D.
Overcome -80°C reaction challenges with new 2,5-dibromoiodobenzene synthesis. 75%+ yield, 99% purity, and industrial scalability for pharma intermediates.
Solve supply chain risks with this green synthesis method for quinone thiazole compounds. No toxic oxidants, high yields, and simple scale-up for pharmaceutical intermediates.
Discover how copper-catalyzed oxidative coupling eliminates costly raw material steps and complex equipment for alpha-carbonyl amide production. Scale with 75-90% yields.
Discover a breakthrough synthesis method for chiral fluorine-containing quaternary carbon compounds with >90% enantioselectivity and mild conditions. Reduce supply chain risks for your API development.
Discover high-yield, cost-effective synthesis of pyrrole derivative anti-tumor compounds. Our CDMO expertise ensures 90%+ yields and 6.5μg/mL IC50 for Hep G2. Scale up with us.
Solve low-yield and low-purity issues in trans-2-aminocyclohexanol production. This patent's 2-methoxyphenylacetic acid resolution method achieves >99%ee and 67% yield, reducing costs for pharma intermediates.
Solve transition metal contamination risks in thio-substituted imidazole synthesis. Our CDMO expertise scales this iodine-catalyzed method to 100MT/yr with >99% purity and consistent supply chain stability.
Solve complex synthesis challenges with this efficient Pd-catalyzed method. Achieve 80-95% yields, broad substrate tolerance, and simplified scale-up for drug development.
Solve high-cost synthesis challenges for Brivaracetam intermediates. New 5-step route with 78% yield reduces raw material costs by 40%—ideal for R&D and procurement teams.
Solve low-yield indole synthesis challenges with this novel palladium-catalyzed method. Achieve 89% yields, mild conditions, and green processing for stable API supply chains.
Discover how asymmetric Povarov reaction with cobalt catalysts enables high-yield, enantioselective synthesis of chiral tetrahydroquinolines for drug development.
Solve supply chain risks in amide synthesis: New molybdenum carbonyl method eliminates toxic CO gas, uses cheap nitroarenes, and achieves high yields for pharma intermediates.
Discover a novel metal-free synthesis for pyrido[1,2-a][1,3,5]-triazin-4-one that eliminates heavy metal waste, reduces production costs, and streamlines your supply chain for pharmaceutical intermediates.
Solve multi-step synthesis challenges with rhodium-catalyzed asymmetric [4+1] cyclization. 91% yield, 95% ee, and mild conditions for stable API intermediates. Contact for CDMO solutions.
Solve supply chain risks with metal-free 5-trifluoromethyl-1,2,4-triazole synthesis. No catalysts, low cost, and green chemistry for API production. Request samples today.
Solve N-acyl indole synthesis challenges with high-yield, scalable Pd-catalyzed carbonylation. Reduce costs and supply chain risks for pharmaceutical intermediates.
Solve high-cost synthesis challenges with room-temperature, water-based production of polysubstituted distyryl indole derivatives. 99% yields, no toxic solvents, and simplified purification.
Discover how multi-component one-pot synthesis of 2-trifluoromethyl quinazolinone reduces production costs by 20-30% while ensuring 99% purity for pharmaceutical applications.